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Hemoglobin (Hb) is a highly conserved molecule present in all life forms and functionally
tied to the complexity of aerobic organisms on earth in utilizing oxygen from the
atmosphere and delivering to cells and tissues. This primary function sustains the energy
requirements of cells and maintains cellular homeostasis. Decades of intensive research
has presented a paradigm shift that shows how the molecule also functions to facilitate
smooth oxygen delivery through the cardiovascular system for cellular bioenergetic
homeostasis and signaling for cell function and defense. These roles are particularly
highlighted in the binding of Hb to gaseous molecules carbon dioxide (CO2), nitric
oxide (NO) and carbon monoxide (CO), while also serving indirectly or directly as
sources of these signaling molecules. The functional activities impacted by Hb outside
of bioenergetics homeostasis, include fertilization, signaling functions, modulation of
inflammatory responses for defense and cell viability. These activities are efficiently
executed while Hb is sequestered safely within the confines of the red blood cell (rbc).
Outside of rbc confines, Hb disaggregates and becomes a danger molecule to cell
survival. In these perpectives, Hb function is broadly dichotomous, either a friend in its
natural environment providing and facilitating the means for cell function or foe when
dislocated from its habitat under stress or pathological condition disrupting cell function.
The review presents insights into how this dichotomy in function manifests.
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Introduction
Hemoglobin (Hb), a protein that is found in all life forms was discovered by F L Hunefeld in
1840 at Liepzig University (Sheftel et al., 2012). It consists of a prosthetic heme molecule [Fe
II coordinated to a tetrapyrole ring (protoporphyrin IX)] joined to globin chains (Schechter,
2008, 2012). Vincenzo Menghini first established that iron in blood is concentrated in the rbc
(Busacchi, 1958). Depending on the species or organism Hb functions to transport or store oxy-
gen, offer protection against reactive oxygen species and detoxify nitric oxide (NO), nitrite and
peroxides (Nishi et al., 2008; Schechter, 2008; Tiso et al., 2011). In humans and vertebrates,
it lies at the cross road of energy transduction from the external environment to the internal
milieu of living systems. Its concentration in blood is 150 g/l so that an adult human body con-
tains approximately 1 kg of Hb (Olsson et al., 2012)The functional activities of hemoglobin are
essentially dichotomous: (a) to provide a means for binding to oxygen and facilitate its deliv-
ery for cellular bioenergetics homeostasis, (b) to be a direct or indirect source of other gaseous
molecules, bind to them and in the process moderate red blood cell (rbc) and cellular health,
function, defense or damage to the cells. These activities are friendly, salutary and sustaining to cell
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health and tissue homeostasis when considered vis-à-vis the high
concentration of hemoglobin in rbc or outright inimical to cell
survival. This review will first present an overview of the gen-
eral function and reactivity of Hb highlighting aspects that are
friendly to cell health and those that are foe like and damaging.
The later part will then have a detailed presentation on the syn-
thesis of hemoglobin in humans, its importance for cell function
in relation to binding to gaseousmolecules and the harm it causes
when released outside of its confinement in rbc.
General Hb Function and Reactivity
The history of life on earth is closely linked to the evolution of
oxygen supply in the atmosphere. This link is central to energy
needs of cells and cellular homeostasis in energy transforma-
tion (Taylor and Cummins, 2011).The evolution of cyanobacteria
with the potential of harnessing energy from the sun with trans-
duction into stored macromolecules in photosynthesis and the
release of oxygen, started the process of oxygenation of the atmo-
sphere on the earth (Semenza, 2007). Life forms with increas-
ing complexity including humans have adapted to oxygen usage
through Hb in respiration where oxygen serves as the final elec-
tron acceptor in the electron transport chain, localized within the
mitochondrion (Rich, 2003). While the structure of Hb is opti-
mal to capture oxygen and deliver it to the tissues, it also presents
a challenge of auto-oxidation that can modify its structure and
lead to generation of reactive oxygen species (ROS) and cellular
damage (Reeder et al., 2008). This dichotomy in function makes
hemoglobin a double edged sword with one face as a friend and
the other a foe under stress.
The primary function of Hb in the capture and release of oxy-
gen is facilitated by heme (with Fe II) which also enables the
reversible binding of carbon monoxide (CO) and NO through
heme based sensor proteins (Chay and Brillhart, 1974; Girvan
and Munro, 2013) while binding of carbon dioxide (CO2) is
allosterically regulated in a heterotropic interaction with the ter-
minal α-amino groups of Hb through rbc band 3 protein com-
plex and soluble adenylcyclase sensing (sAC) (Bauer and Kurtz,
1977; De Rosa et al., 2008; Buck and Levin, 2011). The binding of
hemoglobin to oxygen molecule does not lead to a change in the
oxidative state of iron (Rifkind and Nagababu, 2013). However,
because at physiological pH oxygen has a higher redox poten-
tial than Fe, sometimes hemoglobin undergoes auto-oxidation
with oxygen being reduced to the superoxide anion (O·−2 ) and
generation of metHb/hemin (Fe3+) (Bonaventura et al., 2013).
This reaction is particularly enhanced under hypoxia (Abugo and
Rifkind, 1994). In hemin/metHb, the binding affinity of globin
to heme is weak and can lead to loss of heme. This activity is
known to affect about 1–3% of Hb under normal physiolog-
ical conditions (Alayash, 2004). The generation of superoxide
and hemin may be beneficial or detrimental, but the release of
heme from Hb binding can be damaging when in excess (Aft and
Mueller, 1983; Schmitt et al., 1993; Girvan and Munro, 2013).
Superoxide being a reactive oxygen species (ROS) is important
for signaling function under normal physiology when present in
moderate amounts (Reth, 2002; Taniyama and Griendling, 2003).
Similarly hemin has a net positive charge, so it can react with
nitrites (anions) whether in oxyhemoglobin or deoxyhemoglobin
to regenerate hemin and NO (Cosby et al., 2003; Huang et al.,
2005). Because hemin is unable to bind oxygen, it does not take
part in oxygen transport. NO on the other hand is important for
signaling functions, regulation of vascular tone, modulation of
the immune response and moderation of endothelial adhesion
molecule expression among others (Guzik et al., 2003; Forster-
mann and Sessa, 2012). So a limited release of heme under normal
circumstances is useful. In addition anti-oxidants in the rbc or in
circulation are able to offset any potentially harmful degradative
products. These include glutathione, ascorbic acid, glutathione
peroxidase and peroxiredoxin in the rbc (Ascenzi et al., 2005;
Lutz and Bogdanova, 2013). In circulation the major scavengers
that limit hemoglobin and heme damage are haptoglobin and
hemopexin respectively (Nielsen and Moestrup, 2009; Reeder,
2010; Tolosano et al., 2010; Belcher et al., 2013; Schaer et al.,
2014). However, under stress or pathological conditions, the
moderating effect of the scavengers is overwhelmed so that a cas-
cade of ROS generated fromHb auto-oxidation is not dampened.
In that circumstance NO can react with superoxide to generate
peroxynitrite (ONOO−) which sets up a cascade of ROS gen-
eration that are damaging to cells and tissues (Griendling and
FitzGerald, 2003; Pacher et al., 2007). This is augmented by the
release of heme intravascularly or extravascularly (Schaer et al.,
2013).
Hemoglobin binding to CO and CO2 also serves impor-
tant signaling functions (Maines, 1997; Otterbein et al., 2000;
Schechter, 2008). CO has been shown as a signaling molecule
in the brain, a messenger molecule in the gastrointestinal tract,
and an inducer of hyperpolarization in circular smooth muscle
cells (Maines, 1997; Amano and Camara, 2013). CO2 which is
produced largely in the TCA cycle in cellular metabolism affects
tissue homeostasis (e.g., disrupted pH changes) that can lead
to death or play an important role in inhibiting inflammation
(Buck and Levin, 2011; Cummins et al., 2014). So Hb not only
ensures cellular energy supply through oxygen delivery, but also
facilitates cellular homeostasis through signaling functions of the
gases to which it binds. These functional activities of hemoglobin
are friendly, sustaining and salubrious to cell health and tissue
homeostasis when considered vis-à-vis the high concentration
of hemoglobin in rbc. The review will presently give details on
the synthesis of hemoglobin in humans, its importance for cell
function and the harm it causes when released outside of its
confinement in rbc.
Human Hemoglobin Synthesis
Human hemoglobin is produced in erythroid cells and in adults
is made up of two major tetramers, HbA (97%) consisting of two
alpha and two beta globin polypeptides (α2β2) and HbA2 (2%)
consisting of two alpha and two delta globin polypeptides (α2δ2)
(Perutz, 1979). In the fetus, the Hb molecule referred to as HbF
consists of two alpha and two gamma chains (α2γ2). This pheno-
type can be present in adults up to 1% (Schechter, 2008). After
birth, the gamma chains are replaced with beta chains gradually
(Perutz, 1979).
The genes for the alpha globin chains are located on chro-
mosome 16 whereas chromosome 11 harbors the genes for the
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beta globin chains (Huehns et al., 1964). During ontogenesis, the
embryonic alpha chains (ζ) are replaced by the adult type (α)
which is maintained throughout adulthood (Huehns et al., 1964).
However, the expression of the genes for the globin chains in ery-
throid cells differ based on the developmental stage. The β-globin
genes are arranged sequentially from the 5′ region closest to
the locus control region (LCR), in the order in which they are
expressed during ontogenesis toward the 3′ region (Huehns et al.,
1964). This order is ε (HBE), Gγ(HBG2), Aγ(HBG1), δ(HBD),
and β(HBB)-3′) expressed depending on switches in gene expres-
sion (Figure 1) (Huehns et al., 1964). These switches are from
embryonic (HBE) to fetal (HBG2 and HBG1) stage and fetal to
adult stage (HBD and HBB), regulated by the LCR of the globin
gene cluster (Schechter, 2008; Razin et al., 2012; Moleirinho et al.,
2013). The HBB gene is more highly expressed in adults than the
HBD gene which is why adult hemoglobin is made up largely
(97%) of HbA and about 2% of HbA2. The prosthetic group heme
is synthesized through a series of eight step enzymatic reactions
half of which occurs in the cytosol and a half in mitochondria
(Heinemann et al., 2008; Chiabrando et al., 2014). After the final
step which occurs in the mitochondria matrix, heme is targeted
into hemoproteins either membrane bound or in the cytosol
(Schultz et al., 2010; Larsen et al., 2012; Korolnek and Hamza,
2014). Hemoglobin and myoglobin acquire heme in the cytosol
(Bruns and London, 1965). In these compounds heme (type b) is
non-covalently coordinated to each globin chain (alpha and beta)
through Fe II. It is postulated that heme acquired into cytosolic
globin molecules may be derived frommitochondria or imported
through plasma membrane importers or the endocytic pathway
(Wu et al., 2006; Korolnek and Hamza, 2014).
The Friendly Role of Hemoglobin in Cell
Physiology
The friendly role of Hb is defined in part by its ability to bind
gases in particular O2, NO, CO and CO2 for transport. The bind-
ing affinity of the gases to Hb through heme are in the order
NO>>CO>> O2 (Chapman and Cokelet, 1997; Reeder, 2010;
Olsson et al., 2012). This activity is fundamental to the survival of
multicellular organisms. Indeed the principal function of the car-
diovascular system is essentially to deliver oxygen and nutrients,
while facilitating the removal of carbon dioxide and metabolic
waste in the process (Mairbaurl and Weber, 2012).
Hemoglobin and O2
The transport of oxygen from the lungs to tissues is mediated
by the Hb tetramer with heme iron in the ferrous state (Fe2+)
binding four oxygenmolecules (Reedy andGibney, 2004; Ascenzi
et al., 2005; Buehler and Alayash, 2005). In the lungs oxygen dif-
fuses across the alveolar barrier into the blood where it is bound
by Hb (Eaton, 1974). Through the activity of the cardiovascular
system, oxygen is delivered into tissues by way of the micro-
circulation comprising the arterioles, venules and capillaries to
maintain cellular bioenergetics homeostasis (Haldar and Stam-
ler, 2013). The blood oxygen content which invariably depends
on hemoglobin oxygen saturation determines the amount of oxy-
gen delivered to tissues (Mairbaurl and Weber, 2012; Haldar and
Stamler, 2013). A decrease in pH or an increase in the partial
pressure of CO2 (P CO2) in the systemic capillaries decreases the
affinity of oxygen for Hb (Bohr Effect) leading to tissue deliv-
ery of oxygen (Dash and Bassingthwaighte, 2006). Tissue oxygen
gradient in turn regulates blood flow in the microcirculation, lev-
els of erythropoietin synthesized for erythropoiesis and oxygen
delivery (Siri et al., 1966; Hebbel et al., 1978). Hypoxia defined
as decreased oxygen levels in the microenvironment of cells or
tissues relative to the normal physiological state (demand does
not match supply), increases tissue perfusion, erythropoiesis and
oxygen delivery (Mairbaurl, 1994; Semenza, 2009, 2011). Hyper-
oxia has the reverse effect (Piantadosi, 1999b). When oxygen is
delivered in the tissues, cytochrome oxidase, the final enzyme in
the mitochondria electron transport chain uses the oxygen as the
final electron acceptor to generate ATP.
In addition nitric oxide synthase isoforms utilize molecular
oxygen together with NADPH and arginine as substrates to gen-
erate NO, an important signaling molecule in the central nervous
system (CNS) and peripheral nervous system (Robinson et al.,
2011). NO can also be generated from a reaction between deoxy-
hemoglobin and nitrite following oxygen delivery or in hypoxic
conditions (Huang et al., 2005).
The microcirculation is facilitated by cellular adaptations to
hypoxia which includes improved ventilation and lung perfusion,
augmented cardiac contractility, increased vasodilation and regu-
lated ATP release (Jagger et al., 2001; Sprague et al., 2007; Gladwin
and Kim-Shapiro, 2012). At the molecular level, a transcription
factor, hypoxia inducible factor (HIF) coordinates the responses
to hypoxia (Semenza, 2009; Scholz and Taylor, 2013) through
the activity of hydroxylases. When oxygen is available, hydrox-
ylases (which are absolutely dependent on molecular oxygen)
FIGURE 1 | Organization of the β globin genes on chromosome 11. Gene expression occurs sequentially from the 5′ region in ontogenesis. The lightly shaded
rectangle represent a pseudogene.
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are activated to hydroxylate HIF for degradation, whereas lim-
ited oxygen supply leads to HIF stabilization and expression of
genes affecting vascular tone, erythropoiesis, angiogenesis and
metabolism (Schofield and Ratcliffe, 2005; Taylor, 2008; Eltzschig
and Carmeliet, 2011). These coordinated activities ensure a
smooth link for delivery of oxygen and nutrients to tissues with
removal of waste and carbon dioxide, so that adequate blood
flow through the microcirculation and attendant oxygen sup-
ply is maintained for cell health and survival. Decreases in rbc
hemoglobin as occurs in hemolysis, or pathological states such
as sickle cell disease, malaria, paroxysmal nocturnal hemoglobin-
uria (PNH), directly leads to decrease in tissue oxygen delivery
with attendant pathological consequences (Sikora et al., 2014).
The process of oxygen delivery is also regulated by allosteric
factors including protons (H+), CO2, organic phosphates, chlo-
ride (Cl-) and 2,3-bisphosphoglycerate (Mairbaurl and Weber,
2012). Structural changes at the molecular level in hemoglobin
that alters the affinity of themolecule for oxygen or its response to
the allosteric modulators, also contribute to the reversible bind-
ing to oxygen. The primary function of Hb in oxygen delivery is
clearly also coupled to maintaining energy homeostasis, through
processes that augment oxygen availability to cells and tissues.
Hemoglobin and CO2
In contrast to oxygen, carbon dioxide is generated in multi-
cellular organisms through the TCA cycle and during aerobic
metabolism (Buck and Levin, 2011; Cummins et al., 2014). Car-
bon dioxide not only contributes to the buffering system in blood
but also engages in signaling activity in critical life processes
including sperm activation, blood flow and dampening inflam-
mation (Boatman and Robbins, 1991; Buck and Levin, 2011; Tay-
lor and Cummins, 2011; Cummins et al., 2014). As part of the
buffering systems in the blood, the enzyme carbonic anhydrase
hydrates CO2 to H2CO3 which is transported to the lungs where
it readily dissociates through the activity of carbonic anhydrase to
HCO−3 and H+, with CO2 release and exhalation. Any remain-
ing carbon dioxide in tissues is bound by hemoglobin and sent
through the circulation to the lungs for exhalation. A decrease in
pH or an increase in the partial pressure of oxygen (PO2) in the
pulmonary capillaries decreases the affinity of CO2 for Hb lead-
ing to the release of CO2 from the blood and exhalation (Haldane
effect), (Dash and Bassingthwaighte, 2006).
Elevation in carbon dioxide modulates immune response
through inhibition of NF-κB, IL-6, TNF-alpha and mast cell
degranulation (Oliver et al., 2012; Cummins et al., 2014). These
activities lead to reduced inflammatory response. Carbon diox-
ide sensing is also known to inhibit innate immune response by
altering NF-kB signaling (Helenius et al., 2009; Cummins et al.,
2014). One of the major roles of CO2 sensing is the regulation
of the signaling activity of adenylyl cyclase to generate cAMP
(Kamenetsky et al., 2006). The latter function is particularly
important as cAMP is generated in microdomains throughout
the cell to fine tune intracellular signals through the activity of
soluble adenylyl cyclase (sAC) (Oliver et al., 2012). sAC is not
dependent on G-protein signaling but rather intracellular sig-
nals such as HCO−3 , calcium and ATP (Cummins et al., 2014).
In this regard sAC also participates in CO2 dependent regulation
of ATP generation depending on the amount of CO2 released in
the metabolic activity of the cell (Buck and Levin, 2011). Two sig-
naling activities of sAC that requires mentioning in this review
are the bicarbonate dependent activation of sperm to swim in
the female reproductive tract in a process referred to as capaci-
tation and bicarbonate dependent beating of cilia in the alveolar
epithelial cells that help in defense against inhaled pathogens or
particles (Huckstepp and Dale, 2011). So capacitation for life’s
beginnings and salutary cellular activities are important func-
tions of carbon dioxide sensing modulated by Hb. If one con-
siders that the partial pressure of CO2 regulates ventilation rate
and variations in pH and HCO−3 in the cell can elicit responses
such as changes in breathing rate, metabolism, fertility, immune
response and gene expression, Hb binding to CO2 indirectly
modulates these processes that contribute to the foundation of
life, its sustenance and maintenance of optimal health through
signaling function that protects against pathogens and subdue
inflammation.
Hemoglobin and NO
Nitric oxide (NO) is an important signaling molecule, recognized
in the Nobel Prize award in 1998 for Physiology and Medicine
(Butler, 2006). It is produced in mammalian cells mainly by enzy-
matic and non-enzymatic mechanisms. The enzymatic mecha-
nism is through nitric oxide synthase which is found in three
different isoforms (nNOS:NOS I, iNOS:NOS II, eNOS) depend-
ing on the cell source; n:neurons, i: inducible (macrophages
mainly and sometimes hepatocytes), and e: endothelium (Alder-
ton et al., 2001). Themain substrate for the enzymes is L-arginine,
which is transported into cells by the cationic amino acid
transporters (CAT) (Alderton et al., 2001; Hill et al., 2010).
The co-substrates are reduced nicotinamide adenine dinucleotide
phosphate (NADPH) and oxygen while tetrahydrobiopterin
(BH4), flavin adenine dinucleotide (FAD) and flavin mononu-
cleotide (FMN) function as cofactors modulated by calmodulin
in the redox reaction (Stuehr, 2004; Stuehr et al., 2004). The
non-enzymatic source of NO is largely from nitrites (Lundberg
and Weitzberg, 2010). Deoxyhemoglobin and deoxymyoglobin
by virtue of their nitrite reductase activity (Curtis et al., 2012;
Gladwin and Kim-Shapiro, 2012; Kapil et al., 2014; Gao et al.,
2015) react with nitrites to generate NO under tissue hypoxia or
ischemia. NO acts as a toxin and signaling molecule. The toxic
effect is in the generation of ROS (peroxynitrite) from interac-
tion with heme (ferrous iron) or hemin (ferric iron) following Hb
auto-oxidation to generate superoxide (Pacher et al., 2007; Beck-
man, 2009; Hill et al., 2010). This activity functions in the killing
of microbes but can also lead to damage of proteins, DNA and
lipids derived from peroxynitrite release (Koppenol, 2001). For
example NO is toxic to aconitase in the TCA cycle and heme-
copper terminal oxidases in the respiratory chain, responsible for
peroxynitrites generation, damage to DNA and release of lipid
radicals (Nathan and Ding, 2010; Forstermann and Sessa, 2012).
This obviously is a problem. Fortunately Hb also functions as
nitric oxide dioxygenase (NOD) converting nitric oxide and oxy-
gen to nitrates using NADPH as cofactor so that NO as a ROS
source is attenuated (Gardner, 2012). The NOD function of Hb
ensures continual energy supply necessary for homeostasis in
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cellular bioenergetics and reduction in potential damage to cells
from NOmediated ROS.
NO signaling is either through soluble guanylate cyclase (sGC)
to facilitate vascular homeostasis (blood flow) by modulating
vascular tone, inhibiting thrombosis and regulating the expres-
sion of endothelial adhesion molecules (Shiva et al., 2011) or
through modification of proteins by nitrosylation in metallopro-
teins, nitrosation or oxidation of protein side chains (Hill et al.,
2010; Haldar and Stamler, 2013). It is also important in skeletal
muscle contraction, CNS signaling and host resistance to infec-
tion. Hb NOD function also means that the role of NO as a
signaling molecule can be negatively affected, leading to reduced
blood flow. However, NO removal through NODmediated activ-
ity appears to correlate with activation of sGC so that steady state
levels are achieved. As a compensatory mechanism, Hb andmyo-
globin act as a sink for NO releasing it during times of need and
generate it from nitrites (Gardner, 2012).
Hemoglobin and CO
CO is produced in cells by heme oxygenase (HO encoded
by HMOX genes) mediated breakdown of heme to give CO,
biliverdin and iron (Fe2+) (Tenhunen et al., 1969). Two main
HO isoforms, HO-1 and HO-2 are known which are induced
and constitutive respectively (Tenhunen et al., 1969; Maines
et al., 1974; Yoshida and Kikuchi, 1974; Maines, 2000). HO-1 is
expressed basally in the liver and spleen while HO-2 is basally and
largely expressed in the brain (Immenschuh et al., 2010; Farrugia
and Szurszewski, 2014). Other minor sources include lipid perox-
idation and progesterone activity (Delivoria-Papadopoulos et al.,
1974; Wolff, 1976). Induced HO-1 expression is through a wide
variety of stimuli including inflammation, injury, ROS, hypoxia,
ischemia and hypothermia (Beckman et al., 2009; Immenschuh
et al., 2010; Kacimi et al., 2011). So cells that express HO-2 stably
produce CO, while stimuli dependent CO generation from HO-
1 expression varies depending on cellular environment (Farrugia
and Szurszewski, 2014).
CO is a signaling molecule with antioxidant and anti-
inflammatory activities (Farrugia and Szurszewski, 2014). It acti-
vates soluble guanylyl cyclase (Ramos et al., 1989; Lutz and
Bogdanova, 2013) to generate cyclic GMP (cGMP) for signal-
ing based on the cellular environment (Maines, 2000). In gen-
eral, the signaling function of CO parallels that of NO (although
not as potent) as a neuromessenger and regulator of vascular
tone (Furchgott and Jothianandan, 1991). The two gases are
involved in a negative feedback regulation with NO activating
HO-1 expression, while CO and HO-1 inhibit NO synthesis,
(White and Marletta, 1992; Durante et al., 1997; Zuckerbraun
et al., 2005). CO is biologically more stable thanNO and therefore
can exert effects distant from its site of production in addition
to local effects (Farrugia and Szurszewski, 2014). The functional
activity of CO relates to its high affinity for transition metals.
Since iron is the most abundant transition metal in cells, CO
competes for binding to various heme proteins, particularly Hb.
It binds to hemoglobin with an affinity that is 210–250 times that
of molecular oxygen (Haldane, 1895; Nasmith andGraham, 1906;
Amano and Camara, 2013). Partial occupation of CO at the oxy-
gen binding site of Hb, inhibits oxygen release from other heme
sites (Ryter and Choi, 2013). Hemoglobin can therefore scavenge
cellular CO to reduce its physiological impact but at the same
time render it incapable of carrying oxygen. The baseline car-
boxyhemoglobin (CO-Hb) level in man is 0.1–1.0% (Rudra et al.,
2010). If this level reaches 10–30%, it may cause headache, dizzi-
ness and shortness of breath (Gorman et al., 2003; Sen et al., 2010;
La Fauci et al., 2012). Levels above 30% are harmful and can lead
to severe headache, vomiting, syncope, cardiac arrhythmias and
death (Piantadosi, 1999a; Gorman et al., 2003).
The brain maintains the highest expression of HO, highlight-
ing the importance of CO as a signaling molecule in the brain
(Leﬄer et al., 2011). In the brain, CO dilates cerebral arteries
and arterioles by activating smooth muscle large conductance
Ca2+ activated K+ channels or “Big potassium” channel (BKca)
(Leﬄer et al., 2011) by a mechanism that is unrelated to sGC
activation (Koneru and Leﬄer, 2004; Telezhkin et al., 2011). The
activation of BKca channel activity leads to vasodilation promot-
ing brain vascular system health. CO also provides protection
for the cerebral vasculature (Parfenova et al., 2005). In hemol-
ysis, when heme availability is augmented, heme binding to the
BKca channel deactivates it, which is reversed through CO bind-
ing. Therefore, CO generation in hemolysis makes regulation of
the CO concentration particularly important during ischemia-
reperfusion not only in the brain but also in transplantation
(Sata et al., 2001). CO has emerged as a choice therapeutic agent
in cerebral malaria (CM). CM is a life threatening neurologi-
cal complication of Plasmodium falciparum infection in children
and adults, with the majority of cases (>90%) occurring in chil-
dren <5 years old in sub-Saharan Africa (Pena et al., 2012; Mur-
ray et al., 2014a; Christensen and Eslick, 2015). The incidence
rate is 1120/100,000 annually in endemic Africa, with mortal-
ity of 13-20% (Idro et al., 2010b; Postels and Birbeck, 2013).
Surviving children from the disease endure long term neuro-
logical and cognitive deficits (Brewster et al., 1990; Idro et al.,
2010a; Postels et al., 2012). Although the pathophysiology is not
completely known, current understanding outlines sequestration
of infected RBC leading to changes in brain microcirculation,
cerebral inflammation, vascular dysfunction and breakdown in
blood brain barrier (Shikani et al., 2012; Postels and Birbeck,
2013). Using P. berghei ANKA mouse models, HO-1/CO was
shown to completely inhibit CM and facilitate the resolution
of inflammation in the disease state (Pamplona et al., 2007;
Pena et al., 2012). Because of the potential danger of CO bind-
ing to heme containing molecules in particular Hb, CO releas-
ing molecules with limited formation of CO-Hb are now being
developed (Motterlini et al., 2005; Vera et al., 2005) for CM
treatment. CO is also under evaluation for use as a vasodilator
and inhibitor of ischemia reperfusion injury, an immunosup-
pressant in transplantation, (Sato et al., 2001; Otterbein et al.,
2003), and as an anticancer agent (Wegiel et al., 2013). Additional
roles of CO that are gaining attention include modulation of the
innate and adaptive immune response, inflammation (Otterbein
et al., 2000), cell proliferation, (Morita et al., 1997) apoptosis
(Brouard et al., 2000), mitochondrial biogenesis (Suliman et al.,
2007) and autophagy (Lee et al., 2014). Clearly Hb as a source of
CO and scavenger of CO confers significant salutary impact on
brain health (facilitating nutrient and oxygen delivery, limiting
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inflammation) and enabling maintenance of healthy cerebral
vasculature.
Hemoglobin as an Antioxidant/Defense Molecule
Hemoglobin in other vertebrates contains a number of thi-
ols that exert antioxidant defenses (Moleirinho et al., 2013). In
humans only one reactive cysteine is present at the 93rd posi-
tion of the β-chain (Vitturi et al., 2013). The Hb β93 cysteine
has been observed to moderate heme reactivity leading to auto-
oxidation (Balagopalakrishna et al., 1998). It scavenges reactive
species (hydrogen peroxide and superoxide anion) generated in
the heme pocket of the β-globin chain while inhibiting the activ-
ity of nitrosating and alkylating agents (Bonaventura et al., 1999;
Vitturi et al., 2013). The mechanism of scavenging of hydrogen
peroxide and superoxide anion appears to be the provision of
safe transfer of electrons to traditional antioxidant systems in
the rbc (Winterbourn and Carrell, 1977). This activity is most
effective under high oxygen tension (21%), when the risk of auto-
oxidation is high, being lost at 4% oxygen saturation (Benesch
and Benesch, 1962). When the total concentration of Hb in cir-
culation is taken into consideration, this will have a significant
bearing on cellular defense against hydrogen peroxide reactivity,
generation of ROS and hemoglobin auto-oxidation.
Hb in Cellular Immune Modulation
Central to cellular defense is the host immune response which
adapts to confer protection against infection or tissue damage.
The cells at the center of this adaptation are the myelomonocytic
cell lineage (de Back et al., 2014; Hamilton et al., 2014; Muraille
et al., 2014). In the event of an inflammation or infection,
the blood monocytes are recruited into tissues where they
mature into macrophages or dendritic cells (Geissmann et al.,
2003). Macrophages are polarized into M1 and M2 phenotypes
depending on the type of stimuli they receive and cytokine
profile they generate. In general M1 macrophages are elicited
by pro-inflammatory stimuli, while M2 macrophages by anti-
inflammatory stimuli (Lawrence and Natoli, 2011; Muraille et al.,
2014). In the scheme of activities of hemoglobin modulation of
the generation and function of the gaseous molecules NO, CO,
and CO2, hemoglobin will indirectly influence the M1 and M2
macrophage phenotype and therefore the TH1 and TH2 immune
cytokine profiles, (Lee and Chau, 2002; Alcaraz et al., 2003; Mur-
ray et al., 2014b). This will have significant implication for cellu-
lar defense against damage and pathogens through modulation
of TH1 and TH2 responses (Figure 2). This function requires
further interrogation.
Summary: Hemoglobin: Life’s Pivotal Heart Beat
In the natural environment hemoglobin is the support base for
life, ensuring that vital solar energy captured by plants for pho-
tosynthesis with release of oxygen is channeled to humans and
vertebrates to sustain the energy requirements of cells and life.
It supports life processes by binding to gaseous molecules with
major functions of efficient blood flow in the vasculature, oxy-
gen delivery and bioenergetics homeostasis. The cumulative pro-
cesses for oxygen supply and delivery to tissues is associated with
FIGURE 2 | Hemoglobin functional activities in promoting rbc and cellular health. (see text for details). *Binding of Hb to CO2 is through terminal α-amino
groups of Hb in contrast to the other gases.
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modulation of activities that not only constitute a threat to vas-
cular health but also cellular health in general. These activities
which include mitochondria biogenesis, signaling functions, reg-
ulation of inflammation, immune responses and cell viability,
palpably projects Hb as life’s pivotal heart beat (Figure 3) without
which evolution of life on earth would have been impossible.
Hemoglobin Mediated Tissue Injury: The
Foe
The damaging role of Hb under stress or pathological conditions
fall under four categories:
(a) Hemoglobin auto-oxidation within the rbc
(b) Hemoglobin release outside of its confines in rbc to act as
ROS source in the vasculature and tissues
(c) Hemoglobin scavenging of NO
(d) Heme release from Hb to augment free radical generation
For reviews covering these topics the reader is referred to Olsson
et al. (2012), Schaer et al. (2014), Rother et al. (2005), Larsen et al.
(2012), Gladwin and Sachdev (2012) and Tolosano et al. (2010).
So, how does Hb that provides such a strong support base for life
turn into an enemy?
Hb Auto-Oxidation
In general oxygen reversibly binds to Hb without any change
in the redox state of iron (Bonaventura et al., 2013). How-
ever, at physiological pH, O2 has a higher redox potential than
aqueous iron (Fe3+/Fe2+) so oxygen coordinated to heme in
hemoglobin accepts an electron from Fe2+ heme to form super-
oxide (O−2 ) with oxidation of Fe
2+ to Fe3+ generating met-
hemoglobin (hemin) in a stable complex (HbFe3+)O−2 , (Weiss,
1964; Faivre et al., 1998; Gardner, 2012). This process is Hb auto-
oxidation which is enhanced at acidic pH (low oxygen tension)
but reduced at high oxygen tension (Faivre et al., 1998; Aranda
et al., 2009; Bonaventura et al., 2013). Within the confines of the
rbc, antioxidants enable reduction of Ferric ion to the Fe2+ state
(Antonini, 1974; Edsall, 1986) so that Fe3+ is depleted to cause
no damage. Outside of the rbc auto-oxidation is high posing
significant danger.
Injury Associated with Hb Auto-Oxidation and
Release Outside of the rbc
Outside of the rbc, the major antioxidants are haptoglobin
for Hb (Schaer et al., 2014) and hemopexin, albumin, and
α-1 microglobulin (Fasano et al., 2007; Nordberg et al., 2007;
Tolosano et al., 2010) for heme. When hemolysis is severe the
capacity of the antioxidants to scavenge is overwhelmed, so
metHb and superoxide persist from Hb oxidation to set a cas-
cade of free radical generation to be described presently. First
released hemoglobin is closer to the vascular endothelium and
can also extravasate into tissues as dimers so that ROS generated
in auto-oxidation readily access macromolecules and cause dam-
ages (Nathan and Cunningham-Bussel, 2013; Dutra et al., 2014).
In that scenario tissue NADPH oxidases and vascular NADPH
oxidases facilitate the generation of hydrogen peroxide from
superoxide (Klebanoff, 2005). Superoxide also undergoes dismu-
tation by dismutase (superoxide dismutase) to generate hydrogen
peroxide which can further oxidize oxyHb/Met-Hb to the fer-
ryl (Fe4+ = O2−) form and in the process produce hydroxyl
radical (OH−) through Fenton chemistry (O•−2 + H2O2 →
O2 + OH
−
+ OH−), (Brawn and Fridovich, 1980; Klebanoff
et al., 1989; Pastor et al., 2000; Liochev and Fridovich, 2002).
These are highly reactive species that react with globin chains
and porphyrin rings to form globin and porphyrin ring radi-
cals (Alayash, 2011), DNA to form adducts and lipids to form
peroxides (Cadet et al., 1999; Marnett et al., 2003). The oxi-
dized hemoglobin species may resist scavenging and sustain tis-
sue injury, particularly the vascular endothelium (Goldman et al.,
1998; Rother et al., 2005). Moreover when superoxide is formed
in large quantities, because NO has a free electron in its outer
shell it can react with the superoxide to form peroxynitrite rad-
ical (ONOO−) which has a high reactivity with heme or hemin
and cellular macromolecules (Brawn and Fridovich, 1980; Halli-
well, 1996; Burney et al., 1999; Marnett et al., 2003). Hydrogen
peroxide can also cause intermolecular cross linking of tyrosine
FIGURE 3 | Hemoglobin: life’s core friend in sustaining cardiovascular health. Hb binding to gaseous molecules through heme (O2, CO, NO) or terminal
α-amino groups of Hb (CO2) facilitates cardiovascular function and health.
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residues in the globin chains which are reported to contribute
to atherosclerotic plaques in cardiovascular disease (Doyle et al.,
1985; Halliwell et al., 1999). So severe intravascular and extravas-
cular hemolysis lead to the damage of the vasculature as are
exposed cells and tissues at the cell membrane, mitochondria and
cytoskeleton, a very unfriendly, foe type activity arising from Hb.
Hb and NO Scavenging
Hemoglobin reacts rapidly and irreversibly with nitric oxide
(107m−1 s−1) to generate metHb and nitrate. The rate of this
reaction is such that a very small quantity of Hb can cause
significant NO depletion (Olson et al., 2004). The significance
of this activity was demonstrated in the reversal of acetyl-
choline mediated aortic arc relaxation in rabbits by cell free
Hb at concentrations >1mg/ml (Nakai et al., 1996). NO is
an important signaling molecule in maintaining vascular tone
and blood pressure, angiogenesis, platelet function, vascular
smooth muscle cell proliferation and inflammation (Shaul, 2002;
Sessa, 2004; Atochin and Huang, 2011) as alluded to previ-
ously. By scavenging NO, cell free Hb significantly impair vas-
cular function, bioenergetics homeostasis and portend significant
morbidity.
Heme Release from Cell Free Hb
Oxidized and denatured hemoglobins lose their attached heme
readily leading to heme mediated ROS generation (Balla et al.,
1991a,b). Heme mediated ROS generation is largely attributed to
the redox function of iron, which mediates reductive or oxida-
tive reactions involving the transfer or acceptance of electrons
(Dutra et al., 2014). This redox function makes Hb also function
as a major inducer of ROS because of its large concentration in
the rbc (Jeney et al., 2013). Heme is lipophilic and can interca-
late into cell membranes to disrupt membrane integrity (Schmitt
et al., 1993). Other downstream processes follow similar path to
that outlined for Hb auto oxidation which involves generation of
free radicals (Huertas and Palange, 2011; Dutra and Bozza, 2014)
pro-inflammatory activities and cytotoxicity (Larsen et al., 2012).
The scavenger proteins haptoglobin (Hp) and hemopexin (Hpx)
will normally scavenge cell free Hb and heme respectively obvi-
ating any ROS related activity if not in excess (Hvidberg et al.,
2005; Quaye, 2008; Tolosano et al., 2010; Schaer et al., 2014).
Hb bound haptoglobin is targeted for elimination through the
monocyte/macrophage scavenger receptor CD163 (Schaer et al.,
2014) while is heme first bound by albumin, transferred to Hpx
and the heme-Hpx complex targeted for clearance by the LDL
receptor related protein 1 (LRP 1/CD91 in hepatocytes in partic-
ular (Ascenzi and Fasano, 2007; Schaer et al., 2014). In addition
heme can also be scavenged by α-1 microglobulin (Allhorn et al.,
2002) and high density lipoproteins (Miller and Gladwin, 2012).
When levels of these proteins fall due to excessive hemolysis
then cellular/tissue damage is cascaded. For further reading the
reader is referred to Schaer et al. (2014), Tolosano et al. (2010),
Alayash (2011), Kristiansen et al. (2001), Nielsen and Moestrup
(2009), Hrkal and Klementova (1984), Balla et al. (1991b), Hvid-
berg et al. (2005), Dutra and Bozza (2014) and Dutra et al.
(2014).
Mechanism of Hb Release
Red blood cells lack a nucleus or mitochondria so injury mainly
affects the cell membrane leading to cell rupture and release
of hemoglobin either extra-vascularly or intra-vascularly (Balla
et al., 1991b). In severe insults (infection, complement fixation
and activation, trauma) where the rbc membrane is compro-
mised, hemoglobin is released outside of its confines in the rbc
posing danger not only to the vasculature but also to exposed tis-
sues following extravasation (Jeney et al., 2013; Dutra et al., 2014;
Schaer et al., 2014).
Extravascular and Intravascular Hemolysis
Human red blood cells have a normal life span of 120 days (Dhali-
wal et al., 2004; Sugawara et al., 2010). If this life span is curtailed
either through breakdown of the cell within the blood vessel or
outside of the vessels leading to the release of hemoglobin, the
process is referred to as intravascular or extravascular hemolysis
respectively (Dhaliwal et al., 2004; Sugawara et al., 2010; Mair-
baurl, 2013). Normally when hemoglobin reaches a life span of
120 days, it is removed by the spleen, bone marrow macrophage
phagocytosis and liver Kupffer cells. Part of the trigger for
removal is the presence of Heinz bodies which are aggregates of
oxidized or denatured hemoglobin in the rbc, Howell-jolly bodies
(inclusions of nuclear chromatin), siderocytes (rbcs with granules
of iron that is not part of Hb) and Pappenheimer bodies (inclu-
sion bodies formed by phagosomes ingesting large amounts of
iron) (Winslow et al., 1978; Weatherall, 1995, 2011; Sugawara
et al., 2010). The process of rbc removal by the mononuclear
phagocyte system in the spleen in particular, does not lead to
lysis so endogenous antioxidants including glutathione, ascorbic
acid, catalase, glutathione peroxidase and peroxiredoxin-2 in the
rbc limit the release of hemoglobin extravascularly (Crespo et al.,
1987; Mohandas and Gallagher, 2008). Indeed some hemoglobin
may leak and trigger the release of reactive oxygen species but
this is limited with respect to severity as the hemoglobin scav-
enger receptor CD163, and heme scavenger receptor CD91 effec-
tively scavenge the released hemoglobin through haptoglobin and
hemopexin respectively (Kristiansen et al., 2001; Hvidberg et al.,
2005; Tolosano et al., 2010; Schaer et al., 2013, 2014). Hb can also
be released extravascularly from internal bleedings (trauma) due
to damaged micro- and macro blood vessels.
In intravascular hemolysis, rbcs break up during circulation
from oxidative stress, aging or infection releasing Hb directly into
the vasculature and subsequently heme (Rother et al., 2005; Jeney
et al., 2013; Schaer et al., 2014). Intravascular and extravascular
hemolysis serve as potent sources of free radicals that define the
hazardous nature of Hb. The amount of Hb released depends on
the degree of severity of the oxidative stress or pathological con-
dition which overwhelms natural antioxidants and scavengers in
the rbc and plasma.
Summary: Hemoglobin as a Danger Molecule
Outside of its Confines
In severe extravascular and intravascular hemolysis Hb assumes a
foe like nature serving to propagate ROS generation, disrupt cell
membranes and cell function, the very activities that it supports
Frontiers in Physiology | www.frontiersin.org 8 April 2015 | Volume 6 | Article 96
Quaye Hemoglobin binding to gases and hemolysis
when confined. Fortunately, this foe like activities present under
abnormal conditions requiring external intervention. The nature
and type of the interventions present a challenge but also a major
focus of research the world over.
Conclusion
Hemoglobin is a support base for all life processes physiologi-
cally. In the normal, physiological conditions it is salutary, under
stress (infection or trauma) the nature that promotes cell health
is disrupted leading to real threat and danger to cell function and
survival.
Acknowledgments
The author acknowledges the unflinching support of my family
(Dr Larysa Aleksenko and Noah Quaye,) during the write up of
this review.
References
Abugo, O. O., and Rifkind, J.M. (1994). Oxidation of hemoglobin and the enhance-
ment produced by nitroblue tetrazolium. J. Biol. Chem. 269, 24845–24853.
Aft, R. L., andMueller, G. C. (1983). Hemin-mediated DNA strand scission. J. Biol.
Chem. 258, 12069–12072. doi: 10.1203/PDR.0b013e3181eee738
Alayash, A. I. (2004). Redox biology of blood. Antioxid. Redox Signal. 6, 941–943.
doi: 10.1089/ars.2004.6.941
Alayash, A. I. (2011). Haptoglobin: old protein with new functions. Clin. Chim.
Acta 412, 493–498. doi: 10.1016/j.cca.2010.12.011
Alcaraz, M. J., Fernandez, P., and Guillen, M. I. (2003). Anti-inflammatory actions
of the heme oxygenase-1 pathway. Curr. Pharm. Des. 9, 2541–2551. doi:
10.2174/1381612033453749
Alderton, W. K., Cooper, C. E., and Knowles, R. G. (2001). Nitric oxide syn-
thases: structure, function and inhibition. Biochem. J. 357(Pt 3), 593–615. doi:
10.1042/0264-6021:3570593
Allhorn, M., Berggard, T., Nordberg, J., Olsson, M. L., and Akerstrom, B. (2002).
Processing of the lipocalin alpha(1)-microglobulin by hemoglobin induces
heme-binding and heme-degradation properties. Blood 99, 1894–1901. doi:
10.1182/blood.V99.6.1894
Amano, M. T., and Camara, N. O. (2013). The immunomodulatory role of carbon
monoxide during transplantation. Med. Gas Res. 3:1. doi: 10.1186/2045-9912-
3-1
Antonini, E. (1974). Heme proteins: hemoglobin. FEBS Lett. 40(Suppl.), S98–S104.
doi: 10.1016/0014-5793(74)80691-5
Aranda, R. IV., Cai, H., Worley, C. E., Levin, E. J., Li, R., Olson, J. S., et al. (2009).
Structural analysis of fish versus mammalian hemoglobins: effect of the heme
pocket environment on autooxidation and hemin loss. Proteins 75, 217–230.
doi: 10.1002/prot.22236
Ascenzi, P., Bocedi, A., Visca, P., Altruda, F., Tolosano, E., Beringhelli, T., et al.
(2005). Hemoglobin and heme scavenging. IUBMB Life 57, 749–759. doi:
10.1080/15216540500380871
Ascenzi, P., and Fasano, M. (2007). Heme-hemopexin: a ‘chronosteric’ heme-
protein. IUBMB Life 59, 700–708. doi: 10.1080/15216540701689666
Atochin, D. N., and Huang, P. L. (2011). Role of endothelial nitric oxide
in cerebrovascular regulation. Curr. Pharm. Biotechnol. 12, 1334–1342. doi:
10.2174/138920111798280974
Balagopalakrishna, C., Abugo, O. O., Horsky, J., Manoharan, P. T., Nagababu, E.,
and Rifkind, J. M. (1998). Superoxide produced in the heme pocket of the beta-
chain of hemoglobin reacts with the beta-93 cysteine to produce a thiyl radical.
Biochemistry 37, 13194–13202. doi: 10.1021/bi980941c
Balla, G., Jacob, H. S., Eaton, J. W., Belcher, J. D., and Vercellotti, G. M.
(1991a). Hemin: a possible physiological mediator of low density lipoprotein
oxidation and endothelial injury. Arterioscler. Thromb. 11, 1700–1711. doi:
10.1203/PDR.0b013e3181eee738
Balla, G., Vercellotti, G. M., Muller-Eberhard, U., Eaton, J., and Jacob, H. S.
(1991b). Exposure of endothelial cells to free heme potentiates damage medi-
ated by granulocytes and toxic oxygen species. Lab. Invest. 64, 648–655. doi:
10.1203/PDR.0b013e3181eee738
Bauer, C., and Kurtz, A. (1977). Oxygen-linked carbon dioxide binding to isolated
β subunits of human hemoglobin. J. Biol. Chem. 252, 2952–2955.
Beckman, J. D., Belcher, J. D., Vineyard, J. V., Chen, C., Nguyen, J., Nwaneri, M. O.,
et al. (2009). Inhaled carbon monoxide reduces leukocytosis in a murine model
of sickle cell disease. Am. J. Physiol. Heart Circ. Physiol. 297, H1243–H1253.
doi: 10.1152/ajpheart.00327.2009
Beckman, J. S. (2009). Understanding peroxynitrite biochemistry and its poten-
tial for treating human diseases. Arch. Biochem. Biophys. 484, 114–116. doi:
10.1016/j.abb.2009.03.013
Belcher, J. D., Nath, K. A., and Vercellotti, G. M. (2013). Vasculotoxic and proin-
flammatory effects of plasma heme: cell signaling and cytoprotective responses.
ISRN Oxidative Med. 2013, 831596. doi: 10.1155/2013/831596
Benesch, R. E., and Benesch, R. (1962). The influence of oxygenation on the
reactivity of the—SH groups of hemoglobin. Biochemistry 1, 735–738. doi:
10.1021/bi00911a002
Boatman, D. E., and Robbins, R. S. (1991). Bicarbonate: carbon-dioxide regulation
of sperm capacitation, hyperactivated motility, and acrosome reactions. Biol.
Reprod. 44, 806–813. doi: 10.1095/biolreprod44.5.806
Bonaventura, C., Godette, G., Tesh, S., Holm, D. E., Bonaventura, J., Crumbliss,
A. L., et al. (1999). Internal electron transfer between hemes and Cu(II) bound
at cysteine beta93 promotes methemoglobin reduction by carbon monoxide.
J. Biol. Chem. 274, 5499–5507. doi: 10.1074/jbc.274.9.5499
Bonaventura, C., Henkens, R., Alayash, A. I., Banerjee, S., and Crumbliss, A.
L. (2013). Molecular controls of the oxygenation and redox reactions of
hemoglobin.Antioxid. Redox Signal. 18, 2298–2313. doi: 10.1089/ars.2012.4947
Brawn, K., and Fridovich, I. (1980). Superoxide radical and superoxide dismutases:
threat and defense. Acta Physiol. Scand. Suppl. 492, 9–18.
Brewster, D. R., Kwiatkowski, D., and White, N. J. (1990). Neurological sequelae
of cerebral malaria in children. Lancet 33622, 1039–1043. doi: 10.1016/0140-
6736(90)92498-7
Brouard, S., Otterbein, L. E., Anrather, J., Tobiasch, E., Bach, F. H., Choi,
A. M., et al. (2000). Carbon monoxide generated by heme oxygenase 1
suppresses endothelial cell apoptosis. J. Exp. Med. 192, 1015–1026. doi:
10.1084/jem.192.7.1015
Bruns, G. P., and London, I. M. (1965). The effect of hemin on the synthesis
of globin. Biochem. Biophys. Res. Commun. 18, 236–242. doi: 10.1016/0006-
291X(65)90746-1
Buck, J., and Levin, L. R. (2011). Physiological sensing of carbon diox-
ide/bicarbonate/pH via cyclic nucleotide signaling. Sensors 11, 2112–2128. doi:
10.3390/s110202112
Buehler, P. W., and Alayash, A. I. (2005). Redox biology of blood revisited: the role
of red blood cells inmaintaining circulatory reductive capacity.Antioxid. Redox
Signal. 7, 1755–1760. doi: 10.1089/ars.2005.7.1755
Burney, S., Caulfield, J. L., Niles, J. C., Wishnok, J. S., and Tannenbaum, S. R.
(1999). The chemistry of DNA damage from nitric oxide and peroxynitrite.
Mutat. Res. 424, 37–49. doi: 10.1016/S0027-5107(99)00006-8
Busacchi, V. (1958). Vincenzo Menghini and the discovery of iron in the blood.
Bull. Sci. Med. 130, 202–205.
Butler, A. R. (2006). ‘The heart less bounding’: treating angina pectoris. J. R. Coll.
Phys. Edinb. 36, 185–189.
Cadet, J., Carvalho, V. M., Onuki, J., Douki, T., Medeiros, M. H., and Di Mascio,
P. D. (1999). Purine DNA adducts of 4,5-dioxovaleric acid and 2,4-decadienal.
IARC Sci. Publ. 150, 103–113.
Chapman, G. B., and Cokelet, G. R. (1997). Model studies of leukocyte-
endothelium-blood interactions. II. Hemodynamic impact of leukocytes
adherent to the wall of post-capillary vessels. Biorheology 34, 37–56. doi:
10.1016/S0006-355X(97)00003-6
Frontiers in Physiology | www.frontiersin.org 9 April 2015 | Volume 6 | Article 96
Quaye Hemoglobin binding to gases and hemolysis
Chay, T. R., and Brillhart, D. (1974). Mechanism of cooperative oxygen
binding to hemoglobin: kinetic aspects. Biochemistry 13, 5311–5317. doi:
10.1021/bi00723a009
Chiabrando, D., Mercurio, S., and Tolosano, E. (2014). Heme and erythropoieis:
more than a structural role. Haematologica 99, 973–983. doi: 10.3324/haema-
tol.2013.091991
Christensen, S. S., and Eslick, G. D. (2015). Cerebral malaria as a risk factor for the
development of epilepsy and other long-term neurological conditions: a meta-
analysis. Trans. R. Soc. Trop. Med. Hyg. 109, 233–238. doi: 10.1093/trstmh/
trv005
Cosby, K., Partovi, K. S., Crawford, J. H., Patel, R. P., Reiter, C. D., Martyr, S., et al.
(2003). Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the
human circulation. Nat. Med. 9, 1498–1505. doi: 10.1038/nm954
Crespo, L. M., Novak, T. S., and Freedman, J. C. (1987). Calcium, cell shrink-
age, and prolytic state of human red blood cells. Am. J. Physiol. 252(Pt 1),
C138–C1352.
Cummins, E. P., Selfridge, A. C., Sporn, P. H., Sznajder, J. I., and Taylor, C. T.
(2014). Carbon dioxide-sensing in organisms and its implications for human
disease. Cell. Mol. Life Sci. 71, 831–845. doi: 10.1007/s00018-013-1470-6
Curtis, E., Hsu, L. L., Noguchi, A. C., Geary, L., and Shiva, S. (2012). Oxygen
regulates tissue nitrite metabolism. Antioxid. Redox Signal. 17, 951–961. doi:
10.1089/ars.2011.4242
Dash, R. K., and Bassingthwaighte, J. B. (2006). Simultaneous blood-tissue
exchange of oxygen, carbon dioxide, bicarbonate, hydrogen ion. Ann. Biomed.
Eng. 34, 1129–1148. doi: 10.1007/s10439-005-9066-4
de Back, D. Z., Kostova, E. B., van Kraaij, M., van den Berg, T. K., and van Bruggen,
R. (2014). Of macrophages and red blood cells; a complex love story. Front.
Physiol. 5:9. doi: 10.3389/fphys.2014.00009
Delivoria-Papadopoulos, M., Coburn, R. F., and Forster, R. E. (1974). Cyclic varia-
tion of rate of carbon monoxide production in normal women. J. Appl. Physiol.
36, 49–51.
De Rosa, M. C., Alinovi, C. C., Galtieri, A., Russo, A., and Giardina, B. (2008).
Allosteric properties of hemoglobin and the plasma membrane of the erythro-
cyte: new insights in gas transport and metabolic modulation. IUBMB Life 60,
87–93. doi: 10.1002/iub.15
Dhaliwal, G., Cornett, P. A., and Tierney, L. M. Jr. (2004). Hemolytic anemia. Am.
Fam. Physician 69, 2599–2606.
Doyle, M. P., Herman, J. G., and Dykstra, R. L. (1985). Autocatalytic oxidation of
hemoglobin induced by nitrite: activation and chemical inhibition. J. Free Rad.
Biol. Med. 1, 145–153. doi: 10.1016/0748-5514(85)90019-4
Durante, W., Kroll, M. H., Christodoulides, N., Peyton, K. J., and Schafer, A. I.
(1997). Nitric oxide induces heme oxygenase-1 gene expression and carbon
monoxide production in vascular smooth muscle cells. Circ. Res. 80, 557–564.
doi: 10.1161/01.RES.80.4.557
Dutra, F. F., Alves, L. S., Rodrigues, D., Fernandez, P. L., de Oliveira, R. B.,
Golenbock, D. T., et al. (2014). Hemolysis-induced lethality involves inflam-
masome activation by heme. Proc. Natl. Acad. Sci. U.S.A. 111, E4110–E4118.
doi: 10.1073/pnas.1405023111
Dutra, F. F., and Bozza,M. T. (2014). Heme on innate immunity and inflammation.
Front. Pharmacol. 5:115. doi: 10.3389/fphar.2014.00115
Eaton, J. W. (1974). Oxygen affinity and environmental adaptation. Ann. N.Y.
Acad. Sci. 241, 491–497. doi: 10.1111/j.1749-6632.1974.tb21905.x
Edsall, J. T. (1986). Understanding blood and hemoglobin: an example of inter-
national relations in science. Perspect. Biol. Med. 29(Pt 2), S107–S1023. doi:
10.1353/pbm.1986.0052
Eltzschig, H. K., and Carmeliet, P. (2011). Hypoxia and inflammation. N. Engl. J.
Med. 364, 656–665. doi: 10.1056/NEJMra0910283
Faivre, B., Menu, P., Labrude, P., and Vigneron, C. (1998). Hemoglobin autoox-
idation/oxidation mechanisms and methemoglobin prevention or reduction
processes in the bloodstream. Literature review and outline of autooxida-
tion reaction. Artif. Cells Blood Substit. Immobil. Biotechnol. 26, 17–26. doi:
10.3109/10731199809118943
Farrugia, G., and Szurszewski, J. H. (2014). Carbon monoxide, hydrogen sulfide,
and nitric oxide as signaling molecules in the gastrointestinal tract. Gastroen-
terology 147, 303–313. doi: 10.1053/j.gastro.2014.04.041
Fasano, M., Fanali, G., Leboffe, L., and Ascenzi, P. (2007). Heme binding to albu-
minoid proteins is the result of recent evolution. IUBMB Life 59, 436–440. doi:
10.1080/15216540701474523
Forstermann, U., and Sessa, W. C. (2012). Nitric oxide synthases: regulation and
function. Eur. Heart J. 33, 829–837, 837a–837d. doi: 10.1093/eurheartj/ehr304
Furchgott, R. F., and Jothianandan, D. (1991). Endothelium-dependent and -
independent vasodilation involving cyclic GMP: relaxation induced by nitric
oxide, carbon monoxide and light. Blood Vessels 28, 52–61.
Gao, X., Yang, T., Liu, M., Peleli, M., Zollbrecht, C., Weitzberg, E., et al. (2015).
NADPH oxidase in the renal microvasculature is a primary target for blood
pressure-lowering effects by inorganic nitrate and nitrite. Hypertension 65,
161–170. doi: 10.1161/HYPERTENSIONAHA.114.04222
Gardner, P. R. (2012). Hemoglobin: a nitric-oxide dioxygenase. Scientifica
2012:683729. doi: 10.6064/2012/683729
Geissmann, F., Jung, S., and Littman, D. R. (2003). Blood monocytes consist of two
principal subsets with distinct migratory properties. Immunity 19, 71–82. doi:
10.1016/S1074-7613(03)00174-2
Girvan, H. M., andMunro, A.W. (2013). Heme sensor proteins. J. Biol. Chem. 288,
13194–13203. doi: 10.1074/jbc.R112.422642
Gladwin, M. T., and Kim-Shapiro, D. B. (2012). Vascular biology: nitric oxide
caught in traffic. Nature 491, 344–345. doi: 10.1038/nature11640
Gladwin, M. T., and Sachdev, V. (2012). Cardiovascular abnormalities in sickle cell
disease. J. Am. Coll. Cardiol. 59, 1123–1133. doi: 10.1016/j.jacc.2011.10.900
Goldman, D. W., Breyer, R. J. III., Yeh, D., Brockner-Ryan, B. A., and Alayash, A.
I. (1998). Acellular hemoglobin-mediated oxidative stress toward endothelium:
a role for ferryl iron. Am. J. Physiol. 275(Pt 2), H1046–H1053.
Gorman, D., Drewry, A., Huang, Y. L., and Sames, C. (2003). The clinical
toxicology of carbon monoxide. Toxicology 187, 25–38. doi: 10.1016/S0300-
483X(03)00005-2
Griendling, K. K., and FitzGerald, G. A. (2003). Oxidative stress and cardiovascu-
lar injury: Part I: basic mechanisms and in vivomonitoring of ROS. Circulation
108, 1912–1916. doi: 10.1161/01.CIR.0000093660.86242.BB
Guzik, T. J., Korbut, R., and Adamek-Guzik, T. (2003). Nitric oxide and superoxide
in inflammation and immune regulation. J. Physiol. Pharmacol. 54, 469–487.
Haldane, J. (1895). The action of carbonic oxide on man. J. Physiol. 18, 430–462.
doi: 10.1113/jphysiol.1895.sp000578
Haldar, S. M., and Stamler, J. S. (2013). S-nitrosylation: integrator of cardio-
vascular performance and oxygen delivery. J. Clin. Invest. 123, 101–110. doi:
10.1172/JCI62854
Halliwell, B. (1996). Free radicals, proteins and DNA: oxidative damage versus
redox regulation. Biochem. Soc. Trans. 24, 1023–1027.
Halliwell, B., Zhao, K., and Whiteman, M. (1999). Nitric oxide and peroxynitrite.
The ugly, the uglier and the not so good: a personal view of recent controversies.
Free Radic. Res. 31, 651–669. doi: 10.1080/10715769900301221
Hamilton, T. A., Zhao, C., Pavicic, P. G. Jr., and Datta, S. (2014). Myeloid colony-
stimulating factors as regulators of macrophage polarization. Front. Immunol.
5:554. doi: 10.3389/fimmu.2014.00554
Hebbel, R. P., Eaton, J. W., Berger, E. M., Kronenberg, R. S., Zanjani, E. D.,
and Moore, L. G. (1978). Hemoglobin oxygen affinity and adaptation to
altitude: evidence for pre-adaptation to altitude in humans with left-shifted
oxyhemoglobin dissociation curves. Trans. Assoc. Am. Physicians 91, 212–228.
Heinemann, I. U., Jahn, M., and Jahn, D. (2008). The biochemistry of heme biosyn-
thesis. Arch. Biochem. Biophys. 474, 238–251. doi: 10.1016/j.abb.2008.02.015
Helenius, I. T., Krupinski, T., Turnbull, D. W., Gruenbaum, Y., Silverman, N.,
Johnson, E. A., et al. (2009). Elevated CO2 suppresses specificDrosophila innate
immune responses and resistance to bacterial infection. Proc. Natl. Acad. Sci.
U.S.A. 106, 18710–18715. doi: 10.1073/pnas.0905925106
Hill, B. G., Dranka, B. P., Bailey, S. M., Lancaster, J. R. Jr., and Darley-Usmar, V.
M. (2010). What part of NO don’t you understand? Some answers to the car-
dinal questions in nitric oxide biology. J. Biol. Chem. 285, 19699–19704. doi:
10.1074/jbc.R110.101618
Hrkal, Z., and Klementova, S. (1984). Bilirubin and haeme binding to human
serum albumin studied by spectroscopy methods. Int. J. Biochem. 16, 799–804.
doi: 10.1016/0020-711X(84)90192-7
Huang, Z., Shiva, S., Kim-Shapiro, D. B., Patel, R. P., Ringwood, L. A., Irby, C.
E., et al. (2005). Enzymatic function of hemoglobin as a nitrite reductase that
produces NO under allosteric control. J. Clin. Invest. 115, 2099–2107. doi:
10.1172/JCI24650
Huckstepp, R. T., and Dale, N. (2011). Redefining the components of central CO2
chemosensitivity—towards a better understanding of mechanism. J. Physiol.
589(Pt 23), 5561–5579. doi: 10.1113/jphysiol.2011.214759
Frontiers in Physiology | www.frontiersin.org 10 April 2015 | Volume 6 | Article 96
Quaye Hemoglobin binding to gases and hemolysis
Huehns, E. R., Dance, N., Beaven, G. H., Hecht, F., and Motulsky, A. G. (1964).
Human Embryonic Hemoglobins. Cold Spring Harb. Symp. Quant. Biol. 29,
327–331. doi: 10.1101/SQB.1964.029.01.035
Huertas, A., and Palange, P. (2011). Circulating endothelial progenitor
cells and chronic pulmonary diseases. Eur. Respir. J. 37, 426–431. doi:
10.1183/09031936.00034810
Hvidberg, V., Maniecki, M. B., Jacobsen, C., Hojrup, P., Moller, H. J., and
Moestrup, S. K. (2005). Identification of the receptor scavenging hemopexin-
heme complexes. Blood 106, 2572–2579. doi: 10.1182/blood-2005-03-1185
Idro, R., Kakooza-Mwesige, A., Balyejjussa, S., Mirembe, G., Mugasha, C., Tugu-
misirize, J., et al. (2010a). Severe neurological sequelae and behaviour prob-
lems after cerebral malaria in Ugandan children. BMC Res. Notes 3:104. doi:
10.1186/1756-0500-3-104
Idro, R., Marsh, K., John, C. C., and Newton, C. R. (2010b). Cerebral malaria:
mechanisms of brain injury and strategies for improved neurocognitive out-
come. Pediatr. Res. 68, 267–274. doi: 10.1203/PDR.0b013e3181eee738
Immenschuh, S., Baumgart-Vogt, E., and Mueller, S. (2010). Heme oxygenase-
1 and iron in liver inflammation: a complex alliance. Curr. Drug Targets 11,
1541–1550. doi: 10.2174/1389450111009011541
Jagger, J. E., Bateman, R. M., Ellsworth, M. L., and Ellis, C. G. (2001). Role of ery-
throcyte in regulating local O2 delivery mediated by hemoglobin oxygenation.
Am. J. Physiol. Heart Circ. Physiol. 280, H2833–H2839.
Jeney, V., Eaton, J. W., Balla, G., and Balla, J. (2013). Natural history of the bruise:
formation, elimination, and biological effects of oxidized hemoglobin. Oxid.
Med. Cell. Longev. 2013, 703571. doi: 10.1155/2013/703571
Kacimi, R., Giffard, R. G., and Yenari, M. A. (2011). Endotoxin-activated
microglia injure brain derived endothelial cells via NF-kappaB, JAK-STAT
and JNK stress kinase pathways. J. Inflamm. 8:7. doi: 10.1186/1476-
9255-8-7
Kamenetsky, M., Middelhaufe, S., Bank, E. M., Levin, L. R., Buck, J., and Steeg-
born, C. (2006). Molecular details of cAMP generation in mammalian cells:
a tale of two systems. J. Mol. Biol. 362, 623–639. doi: 10.1016/j.jmb.2006.
07.045
Kapil, V., Weitzberg, E., Lundberg, J. O., and Ahluwalia, A. (2014). Clinical evi-
dence demonstrating the utility of inorganic nitrate in cardiovascular health.
Nitric Oxide 38, 45–57. doi: 10.1016/j.niox.2014.03.162
Klebanoff, S. J. (2005). Myeloperoxidase: friend and foe. J. Leukoc. Biol. 77,
598–625. doi: 10.1189/jlb.1204697
Klebanoff, S. J., Waltersdorph, A. M., Michel, B. R., and Rosen, H. (1989). Oxygen-
based free radical generation by ferrous ions and deferoxamine. J. Biol. Chem.
264, 19765–19771.
Koneru, P., and Leﬄer, C. W. (2004). Role of cGMP in carbon monoxide-
induced cerebral vasodilation in piglets. Am. J. Physiol. Heart Circ. Physiol. 286,
H304–H309. doi: 10.1152/ajpheart.00810.2003
Koppenol, W. H. (2001). 100 years of peroxynitrite chemistry and 11
years of peroxynitrite biochemistry. Redox Rep. 6, 339–341. doi:
10.1179/135100001101536517
Korolnek, T., and Hamza, I. (2014). Like iron in the blood of the people: the
requirement for heme trafficking in iron metabolism. Front. Pharmacol. 5:126.
doi: 10.3389/fphar.2014.00126
Kristiansen, M., Graversen, J. H., Jacobsen, C., Sonne, O., Hoffman, H. J., Law, S.
K., et al. (2001). Identification of the haemoglobin scavenger receptor. Nature
409, 198–201. doi: 10.1038/35051594
La Fauci, G., Weiser, G., Steiner, I. P., and Shavit, I. (2012). Carbon monoxide
poisoning in narghile (water pipe) tobacco smokers. CJEM 14, 57–59.
Larsen, R., Gouveia, Z., Soares, M. P., and Gozzelino, R. (2012). Heme cytotoxi-
city and the pathogenesis of immune-mediated inflammatory diseases. Front.
Pharmacol. 3:77. doi: 10.3389/fphar.2012.00077
Lawrence, T., and Natoli, G. (2011). Transcriptional regulation of macrophage
polarization: enabling diversity with identity. Nat. Rev. Immunol. 11, 750–761.
doi: 10.1038/nri3088
Lee, S., Lee, S. J., Coronata, A. A., Fredenburgh, L. E., Chung, S. W., Perrella, M. A.,
et al. (2014). Carbonmonoxide confers protection in sepsis by enhancing beclin
1-dependent autophagy and phagocytosis. Antioxid. Redox Signal. 20, 432–442.
doi: 10.1089/ars.2013.5368
Lee, T. S., and Chau, L. Y. (2002). Heme oxygenase-1 mediates the anti-
inflammatory effect of interleukin-10 in mice. Nat. Med. 8, 240–246. doi:
10.1038/nm0302-240
Leﬄer, C. W., Parfenova, H., and Jaggar, J. H. (2011). Carbon monoxide as
an endogenous vascular modulator. Am. J. Physiol. Heart Circ. Physiol. 301,
H1–H11. doi: 10.1152/ajpheart.00230.2011
Liochev, S. I., and Fridovich, I. (2002). The Haber-Weiss cycle—70 years
later: an alternative view. Redox Rep. 7, 55–57. author reply 59–60. doi:
10.1179/135100002125000190
Lundberg, J. O., and Weitzberg, E. (2010). The biological role of nitrate
and nitrite: the times they are a-changin’. Nitric Oxide 22, 61–63. doi:
10.1016/j.niox.2009.11.004
Lutz, H. U., and Bogdanova, A. (2013). Mechanisms tagging senescent red
blood cells for clearance in healthy humans. Front. Physiol. 4:387. doi:
10.3389/fphys.2013.00387
Maines, M. D. (1997). The heme oxygenase system: a regulator of sec-
ond messenger gases. Annu. Rev. Pharmacol. Toxicol. 37, 517–554. doi:
10.1146/annurev.pharmtox.37.1.517
Maines, M. D. (2000). The heme oxygenase system and its functions in the brain.
Cell. Mol. Biol. 46, 573–585.
Maines, M. D., Anders, M. W., and Muller-Eberhard, U. (1974). Studies on heme
transfer from microsomal hemoproteins to heme-binding plasma proteins.
Mol. Pharmacol. 10, 204–213.
Mairbaurl, H. (1994). Red blood cell function in hypoxia at altitude and exercise.
Int. J. Sports Med. 15, 51–63. doi: 10.1055/s-2007-1021020
Mairbaurl, H. (2013). Red blood cells in sports: effects of exercise and train-
ing on oxygen supply by red blood cells. Front. Physiol. 4:332. doi:
10.3389/fphys.2013.00332
Mairbaurl, H., and Weber, R. E. (2012). Oxygen transport by hemoglobin. Compr.
Physiol. 2, 1463–1489. doi: 10.1002/cphy.c080113
Marnett, L. J., Riggins, J. N., and West, J. D. (2003). Endogenous generation of
reactive oxidants and electrophiles and their reactions with DNA and protein.
J. Clin. Invest. 111, 583–593. doi: 10.1172/JCI200318022
Miller, A. C., and Gladwin, M. T. (2012). Pulmonary complications of sickle cell
disease. Am. J. Respir. Crit. Care Med. 185, 1154–1165. doi: 10.1164/rccm.
201111-2082CI
Mohandas, N., and Gallagher, P. G. (2008). Red cell membrane: past, present, and
future. Blood 112, 3939–3948. doi: 10.1182/blood-2008-07-161166
Moleirinho, A., Seixas, S., Lopes, A. M., Bento, C., Prata, M. J., and Amorim, A.
(2013). Evolutionary constraints in the beta-globin cluster: the signature of
purifying selection at the delta-globin (HBD) locus and its role in developmen-
tal gene regulation. Genome Biol. Evol. 5, 559–571. doi: 10.1093/gbe/evt029
Morita, T., Mitsialis, S. A., Koike, H., Liu, Y., and Kourembanas, S. (1997). Carbon
monoxide controls the proliferation of hypoxic vascular smooth muscle cells.
J. Biol. Chem. 272, 32804–32809. doi: 10.1074/jbc.272.52.32804
Motterlini, R., Mann, B. E., and Foresti, R. (2005). Therapeutic applications of car-
bonmonoxide-releasingmolecules. Expert Opin. Investig. Drugs 14, 1305–1318.
doi: 10.1517/13543784.14.11.1305
Muraille, E., Leo, O., and Moser, M. (2014). TH1/TH2 paradigm extended:
macrophage polarization as an unappreciated pathogen-driven escape mech-
anism? Front. Immunol. 5:603. doi: 10.3389/fimmu.2014.00603
Murray, C. J., Ortblad, K. F., Guinovart, C., Lim, S. S., Wolock, T. M., and Roberts,
D. A., et al. (2014a). Global, regional, and national incidence and mortal-
ity for HIV, tuberculosis, and malaria during 1990-2013: a systematic analy-
sis for the Global Burden of Disease Study 2013. Lancet 384, 1005–1070. doi:
10.1016/S0140-6736(14)60844-8
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., et al.
(2014b). Macrophage activation and polarization: nomenclature and experi-
mental guidelines. Immunity 41, 14–20. doi: 10.1016/j.immuni.2014.06.008
Nakai, K., Ohta, T., Sakuma, I., Akama, K., Kobayashi, Y., Tokuyama, S.,
et al. (1996). Inhibition of endothelium-dependent relaxation by hemoglobin
in rabbit aortic strips: comparison between acellular hemoglobin deriva-
tives and cellular hemoglobins. J. Cardiovasc. Pharmacol. 28, 115–123. doi:
10.1097/00005344-199607000-00018
Nasmith, G. G., and Graham, D. A. (1906). The haematology of carbon-monoxide
poisoning. J. Physiol. 35, 32–52. doi: 10.1113/jphysiol.1906.sp001179
Nathan, C., and Cunningham-Bussel, A. (2013). Beyond oxidative stress: an immu-
nologist’s guide to reactive oxygen species.Nat. Rev. Immunol. 13, 349–361. doi:
10.1038/nri3423
Nathan, C., and Ding, A. (2010). SnapShot: reactive oxygen intermediates (ROI).
Cell 140, 951-951.e2. doi: 10.1016/j.cell.2010.03.008
Frontiers in Physiology | www.frontiersin.org 11 April 2015 | Volume 6 | Article 96
Quaye Hemoglobin binding to gases and hemolysis
Nielsen, M. J., andMoestrup, S. K. (2009). Receptor targeting of hemoglobin medi-
ated by the haptoglobins: roles beyond heme scavenging. Blood 114, 764–771.
doi: 10.1182/blood-2009-01-198309
Nishi, H., Inagi, R., Kato, H., Tanemoto, M., Kojima, I., Son, D., et al. (2008).
Hemoglobin is expressed by mesangial cells and reduces oxidant stress. J. Am.
Soc. Nephrol. 19, 1500–1508. doi: 10.1681/ASN.2007101085
Nordberg, J., Allhorn, M., Winqvist, I., Akerstrom, B., and Olsson, M. L.
(2007). Quantitative and qualitative evaluation of plasma and urine alpha1-
microglobulin in healthy donors and patients with different haemolytic
disorders and haemochromatosis. Clin. Chim. Acta 386, 31–37. doi:
10.1016/j.cca.2007.07.017
Oliver, K. M., Lenihan, C. R., Bruning, U., Cheong, A., Laffey, J. G., McLough-
lin, P., et al. (2012). Hypercapnia induces cleavage and nuclear localization of
RelB protein, giving insight into CO2 sensing and signaling. J. Biol. Chem. 287,
14004–14011. doi: 10.1074/jbc.M112.347971
Olson, J. S., Foley, E. W., Rogge, C., Tsai, A. L., Doyle, M. P., and
Lemon, D. D. (2004). No scavenging and the hypertensive effect of
hemoglobin-based blood substitutes. Free Rad. Biol. Med. 36, 685–697. doi:
10.1016/j.freeradbiomed.2003.11.030
Olsson, M. G., Allhorn, M., Bulow, L., Hansson, S. R., Ley, D., Olsson, M.
L., et al. (2012). Pathological conditions involving extracellular hemoglobin:
molecular mechanisms, clinical significance, and novel therapeutic opportu-
nities for alpha(1)-microglobulin. Antioxid. Redox Signal. 17, 813–846. doi:
10.1089/ars.2011.4282
Otterbein, L. E., Bach, F. H., Alam, J., Soares, M., Tao Lu, H., Wysk, M., et al.
(2000). Carbonmonoxide has anti-inflammatory effects involving the mitogen-
activated protein kinase pathway. Nat. Med. 6, 422–428. doi: 10.1038/74680
Otterbein, L. E., Zuckerbraun, B. S., Haga, M., Liu, F., Song, R., Usheva, A., et al.
(2003). Carbon monoxide suppresses arteriosclerotic lesions associated with
chronic graft rejection and with balloon injury. Nat. Med. 9, 183–190. doi:
10.1038/nm817
Pacher, P., Beckman, J. S., and Liaudet, L. (2007). Nitric oxide and peroxynitrite in
health and disease. Physiol. Rev. 87, 315–424. doi: 10.1152/physrev.00029.2006
Pamplona, A., Ferreira, A., Balla, J., Jeney, V., Balla, G., Epiphanio, S., et al.
(2007). Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of
experimental cerebral malaria. Nat. Med. 13, 703–710. doi: 10.1038/nm1586
Parfenova, H., Carratu, P., Tcheranova, D., Fedinec, A., Pourcyrous, M., and Lef-
fler, C. W. (2005). Epileptic seizures cause extended postictal cerebral vascular
dysfunction that is prevented by HO-1 overexpression. Am. J. Physiol. Heart
Circ. Physiol. 288, H2843–H2850. doi: 10.1152/ajpheart.01274.2004
Pastor, N., Weinstein, H., Jamison, E., and Brenowitz, M. (2000). A detailed inter-
pretation of OH radical footprints in a TBP-DNA complex reveals the role
of dynamics in the mechanism of sequence-specific binding. J. Mol. Biol. 304,
55–68. doi: 10.1006/jmbi.2000.4173
Pena, A. C., Penacho, N., Mancio-Silva, L., Neres, R., Seixas, J. D., Fernandes, A.
C., et al. (2012). A novel carbon monoxide-releasing molecule fully protects
mice from severe malaria. Antimicrob. Agents Chemother. 56, 1281–1290. doi:
10.1128/AAC.05571-11
Perutz, M. F. (1979). Regulation of oxygen affinity of hemoglobin: influence of
structure of the globin on the heme iron. Annu. Rev. Biochem. 48, 327–386.
doi: 10.1146/annurev.bi.48.070179.001551
Piantadosi, C. A. (1999a). Diagnosis and treatment of carbonmonoxide poisoning.
Respir. Care Clin. N. Am. 5, 183–202.
Piantadosi, C. A. (1999b). Physiology of hyperbaric hyperoxia. Respir. Care Clin.
North Am. 5, 7–19, v.
Postels, D. G., and Birbeck, G. L. (2013). Cerebral malaria. Handb. Clin. Neurol.
114, 91–102. doi: 10.1016/B978-0-444-53490-3.00006-6
Postels, D. G., Taylor, T. E., Molyneux, M., Mannor, K., Kaplan, P. W., Seydel, K.
B., et al. (2012). Neurologic outcomes in retinopathy-negative cerebral malaria
survivors. Neurology 79, 1268–1272. doi: 10.1212/WNL.0b013e31826aacd4
Quaye, I. K. (2008). Haptoglobin, inflammation and disease. Trans. R. Soc. Trop.
Med. Hyg. 102, 735–742. doi: 10.1016/j.trstmh.2008.04.010
Ramos, K. S., Lin, H., and McGrath, J. J. (1989). Modulation of cyclic guano-
sine monophosphate levels in cultured aortic smooth muscle cells by car-
bon monoxide. Biochem. Pharmacol. 38, 1368–1370. doi: 10.1016/0006-
2952(89)90347-X
Razin, S. V., Ulianov, S. V., Ioudinkova, E. S., Gushchanskaya, E. S., Gavrilov, A.
A., and Iarovaia, O. V. (2012). Domains of alpha- and beta-globin genes in
the context of the structural-functional organization of the eukaryotic genome.
Biochemistry 77, 1409–1423. doi: 10.1134/S0006297912130019
Reeder, B. J. (2010). The redox activity of hemoglobins: from physiologic func-
tions to pathologic mechanisms. Antioxid. Redox Signal. 13, 1087–1123. doi:
10.1089/ars.2009.2974
Reeder, B. J., Cutruzzola, F., Bigotti, M. G., Hider, R. C., and Wilson, M. T. (2008).
Tyrosine as a redox-active center in electron transfer to ferryl heme in globins.
Free Radic. Biol. Med. 44, 274–283. doi: 10.1016/j.freeradbiomed.2007.06.030
Reedy, C. J., and Gibney, B. R. (2004). Heme protein assemblies. Chem. Rev. 104,
617–649. doi: 10.1021/cr0206115
Reth, M. (2002). Hydrogen peroxide as second messenger in lymphocyte activa-
tion. Nat. Immunol. 3, 1129–1134. doi: 10.1038/ni1202-1129
Rich, P. R. (2003). The molecular machinery of Keilin’s respiratory chain. Biochem.
Soci. Trans. 31(Pt 6), 1095–1105. doi: 10.1042/BST0311095
Rifkind, J.M., andNagababu, E. (2013). Hemoglobin redox reactions and red blood
cell aging. Antioxid. Redox Signal. 18, 2274–2283. doi: 10.1089/ars.2012.4867
Robinson, M. A., Baumgardner, J. E., and Otto, C. M. (2011). Oxygen-dependent
regulation of nitric oxide production by inducible nitric oxide synthase. Free
Rad. Biol. Med. 51, 1952–1965. doi: 10.1016/j.freeradbiomed.2011.08.034
Rother, R. P., Bell, L., Hillmen, P., and Gladwin, M. T. (2005). The clinical seque-
lae of intravascular hemolysis and extracellular plasma hemoglobin: a novel
mechanism of human disease. JAMA 293, 1653–1662. doi: 10.1001/jama.293.
13.1653
Rudra, C. B., Williams, M. A., Sheppard, L., Koenig, J. Q., Schiff, M. A., Frederick,
I. O., et al. (2010). Relation of whole blood carboxyhemoglobin concentra-
tion to ambient carbon monoxide exposure estimated using regression. Am.
J. Epidemiol. 171, 942–951. doi: 10.1093/aje/kwq022
Ryter, S. W., and Choi, A. M. (2013). Carbon monoxide: present and future
indications for a medical gas. Korean J. Intern. Med. 28, 123–140. doi:
10.3904/kjim.2013.28.2.123
Sata, M., Luo, Z., and Walsh, K. (2001). Fas ligand overexpression on allo-
graft endothelium inhibits inflammatory cell infiltration and transplant-
associated intimal hyperplasia. J. Immunol. 166, 6964–6971. doi: 10.4049/jim-
munol.166.11.6964
Sato, K., Balla, J., Otterbein, L., Smith, R. N., Brouard, S., Lin, Y., et al. (2001).
Carbon monoxide generated by heme oxygenase-1 suppresses the rejec-
tion of mouse-to-rat cardiac transplants. J. Immunol. 166, 4185–4194. doi:
10.4049/jimmunol.166.6.4185
Schaer, D. J., Buehler, P. W., Alayash, A. I., Belcher, J. D., and Vercellotti, G.
M. (2013). Hemolysis and free hemoglobin revisited: exploring hemoglobin
and hemin scavengers as a novel class of therapeutic proteins. Blood 121,
1276–1284. doi: 10.1182/blood-2012-11-451229
Schaer, D. J., Vinchi, F., Ingoglia, G., Tolosano, E., and Buehler, P. W.
(2014). Haptoglobin, hemopexin, and related defense pathways-basic sci-
ence, clinical perspectives, and drug development. Front. Physiol. 5:415. doi:
10.3389/fphys.2014.00415
Schechter, A. N. (2008). Hemoglobin research and the origins of molecular
medicine. Blood 112, 3927–3938. doi: 10.1182/blood-2008-04-078188
Schechter, A. N. (2012). Introduction to the symposium on synthetic life. Perspect.
Biol. Med. 55, 467–469. doi: 10.1353/pbm.2012.0049
Schmitt, T. H., Frezzatti, W. A. Jr., and Schreier, S. (1993). Hemin-induced
lipid membrane disorder and increased permeability: a molecular model
for the mechanism of cell lysis. Arch. Biochem. Biophys. 307, 96–103. doi:
10.1006/abbi.1993.1566
Schofield, C. J., and Ratcliffe, P. J. (2005). Signalling hypoxia by HIF hydroxylases.
Biochem. Biophys. Res. Commun. 338, 617–626. doi: 10.1016/j.bbrc.2005.08.111
Scholz, C. C., and Taylor, C. T. (2013). Targeting the HIF pathway in
inflammation and immunity. Curr. Opin. Pharmacol. 13, 646–653. doi:
10.1016/j.coph.2013.04.009
Schultz, I. J., Chen, C., Paw, B. H., and Hamza, I. (2010). Iron and por-
phyrin trafficking in heme biogenesis. J. Biol. Chem. 285, 26753–26759. doi:
10.1074/jbc.R110.119503
Semenza, G. L. (2007). Life with oxygen. Science 318, 62–64. doi: 10.1126/sci-
ence.1147949
Semenza, G. L. (2009). Regulation of vascularization by hypoxia-inducible factor
1. Ann. N.Y. Acad. Sci. 1177, 2–8. doi: 10.1111/j.1749-6632.2009.05032.x
Semenza, G. L. (2011). Oxygen sensing, homeostasis, and disease. N. Engl. J. Med.
365, 537–547. doi: 10.1056/NEJMra1011165
Frontiers in Physiology | www.frontiersin.org 12 April 2015 | Volume 6 | Article 96
Quaye Hemoglobin binding to gases and hemolysis
Sen, S., Peltz, C., Beard, J., and Zeno, B. (2010). Recurrent carbon monox-
ide poisoning from cigarette smoking. Am. J. Med. Sci. 340, 427–428. doi:
10.1097/MAJ.0b013e3181ef712d
Sessa, W. C. (2004). eNOS at a glance. J. Cell Sci. 117(Pt 12), 2427–2429. doi:
10.1242/jcs.01165
Shaul, P. W. (2002). Regulation of endothelial nitric oxide synthase:
location, location, location. Annu. Rev. Physiol. 64, 749–774. doi:
10.1146/annurev.physiol.64.081501.155952
Sheftel, A. D., Mason, A. B., and Ponka, P. (2012). The long history of iron in the
Universe and in health and disease. Biochim. Biophys. Acta 1820, 161–187. doi:
10.1016/j.bbagen.2011.08.002
Shikani, H. J., Freeman, B. D., Lisanti, M. P., Weiss, L. M., Tanowitz, H. B., and
Desruisseaux, M. S. (2012). Cerebral malaria: we have come a long way. Am. J.
Pathol. 181, 1484–1492. doi: 10.1016/j.ajpath.2012.08.010
Shiva, S., Rassaf, T., Patel, R. P., and Gladwin, M. T. (2011). The detection of the
nitrite reductase and NO-generating properties of haemoglobin by mitochon-
drial inhibition. Cardiovasc. Res. 89, 566–573. doi: 10.1093/cvr/cvq327
Sikora, J., Orlov, S. N., Furuya, K., and Grygorczyk, R. (2014). Hemolysis is a pri-
mary ATP-release mechanism in human erythrocytes. Blood 124, 2150–2157.
doi: 10.1182/blood-2014-05-572024
Siri, W. E., Van Dyke, D. C., Winchell, H. S., Pollycove, M., Parker, H. G.,
and Cleveland, A. S. (1966). Early erythropoietin, blood, and physiological
responses to severe hypoxia in man. J. Appl. Physiol. 21, 73–80.
Sprague, R. S., Stephenson, A. H., and Ellsworth, M. L. (2007). Red not dead: sig-
naling in and from erythrocytes. Trends Endocrinol. Metab. 18, 350–355. doi:
10.1016/j.tem.2007.08.008
Stuehr, D. J. (2004). Enzymes of the L-arginine to nitric oxide pathway. J. Nutrition
134(Suppl.), 2748S–2751S. discussion: 2765S–2767S.
Stuehr, D. J., Wei, C. C., Santolini, J., Wang, Z., Aoyagi, M., and Getzoff, E. D.
(2004). Radical reactions of nitric oxide synthases. Biochem. Soc. Symp. 71,
39–49.
Sugawara, Y., Hayashi, Y., Shigemasa, Y., Abe, Y., Ohgushi, I., Ueno, E., et al.
(2010). Molecular biosensing mechanisms in the spleen for the removal of aged
and damaged red cells from the blood circulation. Sensors 10, 7099–7121. doi:
10.3390/s100807099
Suliman, H. B., Carraway, M. S., Tatro, L. G., and Piantadosi, C. A. (2007). A new
activating role for CO in cardiac mitochondrial biogenesis. J. Cell Sci. 120 (Pt
2), 299–308. doi: 10.1242/jcs.03318
Taniyama, Y., and Griendling, K. K. (2003). Reactive oxygen species in the vascu-
lature: molecular and cellular mechanisms. Hypertension 42, 1075–1081. doi:
10.1161/01.HYP.0000100443.09293.4F
Taylor, C. T. (2008). Interdependent roles for hypoxia inducible factor and nuclear
factor-kappaB in hypoxic inflammation. J. Physiol. 586(Pt 17), 4055–4059. doi:
10.1113/jphysiol.2008.157669
Taylor, C. T., and Cummins, E. P. (2011). Regulation of gene expression by carbon
dioxide. J. Physiol. 589(Pt 4), 797–803. doi: 10.1113/jphysiol.2010.201467
Telezhkin, V., Brazier, S. P., Mears, R., Muller, C. T., Riccardi, D., and Kemp, P.
J. (2011). Cysteine residue 911 in C-terminal tail of human BK(Ca)alpha chan-
nel subunit is crucial for its activation by carbon monoxide. Pflugers Arch. 461,
665–675. doi: 10.1007/s00424-011-0924-7
Tenhunen, R., Marver, H. S., and Schmid, R. (1969). The enzymatic conversion of
hemoglobin to bilirubin. Trans. Assoc. Am. Physicians 82, 363–371.
Tiso, M., Tejero, J., Basu, S., Azarov, I., Wang, X., Simplaceanu, V., et al. (2011).
Human neuroglobin functions as a redox-regulated nitrite reductase. J. Biol.
Chem. 286, 18277–18289. doi: 10.1074/jbc.M110.159541
Tolosano, E., Fagoonee, S., Morello, N., Vinchi, F., and Fiorito, V. (2010). Heme
scavenging and the other facets of hemopexin. Antioxid. Redox Signal. 12,
305–320. doi: 10.1089/ars.2009.2787
Vera, T., Henegar, J. R., Drummond, H. A., Rimoldi, J. M., and Stec, D.
E. (2005). Protective effect of carbon monoxide-releasing compounds in
ischemia-induced acute renal failure. J. Am. Soc. Nephrol. 16, 950–958. doi:
10.1681/ASN.2004090736
Vitturi, D. A., Sun, C. W., Harper, V. M., Thrash-Williams, B., Cantu-Medellin,
N., Chacko, B. K., et al. (2013). Antioxidant functions for the hemoglobin
beta93 cysteine residue in erythrocytes and in the vascular compartment
in vivo. Free Radic. Biol. Med. 55, 119–129. doi: 10.1016/j.freeradbiomed.2012.
11.003
Weatherall, D. (2011). The inherited disorders of haemoglobin: an increasingly
neglected global health burden. Indian J. Med. Res. 134, 493–497.
Weatherall, D. J. (1995). The molecular basis for phenotypic diversity of
genetic disease. Ann. N.Y. Acad. Sci. 758, 245–260. doi: 10.1111/j.1749-
6632.1995.tb24832.x
Wegiel, B., Gallo, D., Csizmadia, E., Harris, C., Belcher, J., Vercellotti, G. M.,
et al. (2013). Carbon monoxide expedites metabolic exhaustion to inhibit
tumor growth. Cancer Res. 73, 7009–7021. doi: 10.1158/0008-5472.CAN-
13-1075
Weiss, J. J. (1964). Nature of the iron-oxygen bond in oxyhaemoglobin.Nature 202,
83–84. doi: 10.1038/202083b0
White, K. A., and Marletta, M. A. (1992). Nitric oxide synthase is a cytochrome P-
450 type hemoprotein. Biochemistry 31, 6627–6631. doi: 10.1021/bi00144a001
Winslow, R. M., Morrissey, J. M., Berger, R. L., Smith, P. D., and Gibson, C. C.
(1978). Variability of oxygen affinity of normal blood: an automated method of
measurement. J. Appl. Physiol. 45, 289–297.
Winterbourn, C. C., and Carrell, R. W. (1977). Oxidation of human haemoglobin
by copper. Mechanism and suggested role of the thiol group of residue beta-93.
Biochem. J. 165, 141–148.
Wolff, D. G. (1976). The formation of carbon monoxide during peroxidation
of microsomal lipids. Biochem. Biophys. Res. Commun. 73, 850–857. doi:
10.1016/0006-291X(76)90199-6
Wu, C. J., Sheu, J. R., Chen, H. H., Liao, H. F., Yang, Y. C., Yang, S., et al.
(2006). Modulation of monocyte-derived dendritic cell differentiation is asso-
ciated with ischemic acute renal failure. J. Surg. Res. 132, 104–111. doi:
10.1016/j.jss.2005.09.029
Yoshida, T., and Kikuchi, G. (1974). Sequence of the reaction of heme catabolism
catalyzed by the microsomal heme oxygenase system. FEBS Lett. 48, 256–261.
doi: 10.1016/0014-5793(74)80481-3
Zuckerbraun, B. S., McCloskey, C. A., Gallo, D., Liu, F., Ifedigbo, E., Otterbein, L.
E., et al. (2005). Carbon monoxide prevents multiple organ injury in a model of
hemorrhagic shock and resuscitation. Shock 23, 527–532.
Conflict of Interest Statement: The author declares that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Copyright © 2015 Quaye. This is an open-access article distributed under the terms of
the Creative Commons Attribution License (CC BY). The use, distribution or repro-
duction in other forums is permitted, provided the original author(s) or licensor are
credited and that the original publication in this journal is cited, in accordance with
accepted academic practice. No use, distribution or reproduction is permitted which
does not comply with these terms.
Frontiers in Physiology | www.frontiersin.org 13 April 2015 | Volume 6 | Article 96
